Tolazamide (Compound)

Synonyms:tolazamide, 1156-19-0, Tolinase, Norglycin, Tolanase, Diabewas, Tolazolamide, Tolazamida, Tolazamidum, 1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea, U-17835, N-(p-Toluenesulfonyl)-N'-hexamethyleniminourea, NSC-70762, 1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea, 4-(p-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide, NCI-C03327, 1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea, U 17835, CCRIS 591, Urea, 1-(hexahydroazepin-1-yl)-3-p-tolylsulfonyl-, EINECS 214-588-3, Urea, 1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)-, BRN 1323565, Benzenesulfonamide, N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-, N-(azepan-1-ylcarbamoyl)-4-methylbenzenesulfonamide, 9LT1BRO48Q, Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)amino)carbonyl)-4-methyl-, MLS000028534, 1-(Hexahydro-1H-azepin-1-yl)-3-(p-toluenesulfonyl)urea, CHEBI:9613, N-[(azepan-1-ylamino)carbonyl]-4-methylbenzenesulfonamide, DTXSID3021358, N-(((Hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methylbenzenesulfonamide, NSC70762, NCGC00016009-10, SMR000058290, CAS-1156-19-0, Tolazamidum [INN-Latin], Tolazamida [INN-Spanish], DTXCID401358, 1-(((((4-Methylphenyl)sulfonyl)amino)carbonyl)amino)azepane, Tolinase (TN), HSDB 3192, SR-01000003105, NSC 70762, UNII-9LT1BRO48Q, 1-[(Azepan-1-ylamino)carbonyl]-4-methylbenzenesulfonamide, 1-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]azepane, Ronase, AI3-50826, N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide, Prestwick_865, Tolazamide [USAN:USP:INN:BAN:JAN], Spectrum_001269, TOLAZAMIDE [MI], TOLAZAMIDE [INN], TOLAZAMIDE [JAN], Opera_ID_1740, Prestwick0_000554, Prestwick1_000554, Prestwick2_000554, Prestwick3_000554, Spectrum2_001449, Spectrum3_001473, Spectrum4_000240, Spectrum5_001204, Lopac-T-2408, TOLAZAMIDE [HSDB], TOLAZAMIDE [USAN], TOLAZAMIDE [VANDF], CHEMBL817, Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methyl-, T 2408, TOLAZAMIDE [MART.], 3-azepan-1-yl-1-(4-methylphenyl)sulfonyl-urea, NCIOpen2_008361, TOLAZAMIDE [USP-RS], TOLAZAMIDE [WHO-DD], CBiol_001918, Lopac0_001195, Oprea1_061180, SCHEMBL34417, BSPBio_000627, BSPBio_001505, BSPBio_003025, KBioGR_000225, KBioGR_000939, KBioSS_000225, KBioSS_001749, Tolazamide (JAN/USP/INN), 1-(azepan-1-yl)-3-(4-methylbenzenesulfonyl)urea, 5-20-04-00062 (Beilstein Handbook Reference), MLS001076161, DivK1c_000212, SPECTRUM1501201, SPBio_001317, SPBio_002548, BPBio1_000691, GTPL6847, WLN: T7NTJ AMVMSWR D1, TOLAZAMIDE [ORANGE BOOK], BCBcMAP01_000061, HMS500K14, KBio1_000212, KBio2_000225, KBio2_001749, KBio2_002793, KBio2_004317, KBio2_005361, KBio2_006885, KBio3_000449, KBio3_000450, KBio3_002525, NINDS_000212, Bio1_000204, Bio1_000693, Bio1_001182, Bio2_000225, Bio2_000705, HMS1361L07, HMS1569P09, HMS1791L07, HMS1921P19, HMS1989L07, HMS2089L10, HMS2092L09, HMS2096P09, HMS2232L21, HMS3259O18, HMS3263P11, HMS3369L04, HMS3402L07, HMS3713P09, Pharmakon1600-01501201, TOLAZAMIDE [USP MONOGRAPH], BCP23550, HY-B0920, Tox21_110281, Tox21_201507, Tox21_300416, Tox21_501195, CCG-39178, NSC758149, AKOS015913823, N-[[(Hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methylbenzenesulfonamide, Tox21_110281_1, DB00839, KS-1438, LP01195, NC00590, NSC-758149, SDCCGSBI-0051162.P004, Benzenesulfonamide, {N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-}, IDI1_000212, IDI1_033975, NCGC00016009-01, NCGC00016009-02, NCGC00016009-03, NCGC00016009-04, NCGC00016009-05, NCGC00016009-06, NCGC00016009-07, NCGC00016009-08, NCGC00016009-09, NCGC00016009-11, NCGC00016009-12, NCGC00016009-13, NCGC00016009-14, NCGC00016009-15, NCGC00016009-16, NCGC00016009-17, NCGC00016009-19, NCGC00016009-24, NCGC00023701-03, NCGC00023701-04, NCGC00023701-05, NCGC00023701-06, NCGC00023701-07, NCGC00023701-08, NCGC00023701-09, NCGC00023701-10, NCGC00254501-01, NCGC00259058-01, NCGC00261880-01, 1-(azepan-1-yl)-3-(p-tolylsulfonyl)urea, SBI-0051162.P003, AB00052247, EU-0101195, FT-0675268, SW196991-3, TOLBUTAMIDE IMPURITY C [EP IMPURITY], C71499, D00379, AB00052247-15, AB00052247_16, AB00052247_17, A921617, 1-(azepan-1-yl)-3-[(4-methylbenzene)sulfonyl]urea, 3-(Azepan-1-yl)-1-(4-methylphenyl)Sulfonyl-Urea, Q7814101, SR-01000003105-2, SR-01000003105-4, SR-01000003105-5, SR-01000003105-8, W-109110, BRD-K32164935-001-06-8, BRD-K32164935-001-17-5, BRD-K32164935-001-28-2, F2173-1137, Z1575267190, 1-(4-Methylphenylsulfonyl)-3-(hexahydro-1H-azepin-1-yl)urea, 1-[(([(4-Methylphenyl)sulfonyl]amino)carbonyl)amino]azepane #, Tolazamide, United States Pharmacopeia (USP) Reference Standard, Benzenesulfonamide, N-[[(hexahydro-1-azepinyl)amino]carbonyl]-4-methyl-

Pubchem:PUBCHEM:5503

Id:859746a9-a384-53de-8637-c63f77dde4ae

Description:nan